senateStanding
Judiciary Committee
- Referred To
- Markup By
- Reported By
← Back to federal legislation
S. 527In committee
Prescription Pricing for the People Act of 2025
Introduced: Feb 11, 2025
Latest action date: Apr 10, 2025
Your view
Current stage
In committee
The most advanced recorded stage is committee consideration.
Introduced
Feb 11, 2025
Latest action
Apr 10, 2025
Recorded roll calls
0
Civixly topics
What this legislation is about
Civixly topics make federal and state legislation comparable. They are derived from the official CRS policy area and legislative subjects.
Official CRS policy area
Commerce
View 11 official legislative subjects
Business ethicsBusiness recordsCompetition and antitrustCongressional oversightConsumer affairsHealth care costs and insuranceHealth information and medical recordsInflation and pricesPrescription drugsRetail and wholesale tradesSupply chain
Bill Summary
Prescription Pricing for the People Act of 2025
This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs.
The report must address whether pharmacy benefit managers (PBMs) (1) reimburse pharmacies owned by the PBM at a higher price than other pharmacies, and (2) implement formulary designs to increase the market share of higher-cost prescription drugs or depress the market share of lower-cost prescription drugs.
The FTC also must provide recommendations to increase transparency in the supply chain, prevent anticompetitive practices, and ensure that consumers benefit from cost savings or efficiencies that result from mergers and consolidations.
Additionally, the FTC must report the number and nature of complaints the FTC receives relating to an allegation of anticompetitive conduct by a manufacturer of a sole-source drug.
Committee activity
Committees and subcommittees that received, reviewed, marked up, or reported this legislation.
Official committee record ↗
Amendments
Proposed changes to this measure, with their latest official outcome or action from Congress.gov.
No amendments are listed for this measure.
Checked against Congress.gov Sep 12, 2026.
Action timeline
Newest action first. Action language comes from the official Congress.gov record.
View full action timeline6 actions
Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.
CommitteeLibrary of CongressPlaced on Senate Legislative Calendar under General Orders. Calendar No. 42.
CalendarsSenateCommittee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.
CommitteeSenateCommittee on the Judiciary. Ordered to be reported without amendment favorably.
CommitteeSenateRead twice and referred to the Committee on the Judiciary.
IntroReferralSenateIntroduced in Senate
IntroReferralLibrary of Congress
Roll-call votes
Recorded House and Senate votes connected to this bill. Your representatives appear first when available.
No connected roll-call votes are currently available for this bill.
Discussion
0 comments
Sign in to join the discussion.Comments are publicly visible.
Loading comments...